Vivos Therapeutics, Inc. Shareholders' Equity
Vivos Therapeutics, Inc. (VVOS) had Shareholders' Equity of -$3.81 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$3.81M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.14M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.49M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.53M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$3.81M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$1.14M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | -$1.49M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.53M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $4.58M 10-Q · filed 2025-11-19 | |
| 2025-03-31 | $4.41M 10-Q · filed 2025-11-19 | |
| 2024-12-31 | $7.95M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $7.67M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $6.35M 10-Q · filed 2025-11-19 | |
| 2024-03-31 | $582.00K 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $411.00K 10-Q · filed 2025-11-19 | |
| 2023-09-30 | $46.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $2.11M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $6.99M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $4.80M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $9.86M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $14.84M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $21.04M 10-Q · filed 2023-11-14 | $20.86M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $25.54M 10-K/A · filed 2024-07-30 | |
| 2021-09-30 | $32.47M 10-Q · filed 2022-12-20 | $32.47M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $36.48M 10-Q · filed 2022-12-20 | $36.48M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $14.34M 10-Q · filed 2022-12-20 | $14.34M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $16.92M 10-K · filed 2023-03-30 | $16.92M 10-K · filed 2021-03-25 |
| 2020-09-30 | -$1.93M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$2.20M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$1.51M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | -$2.94M 10-K · filed 2022-03-31 | -$2.94M 10-K · filed 2021-03-25 |
| 2018-12-31 | $4.83M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |